|
| N-[3-(2-amino-1H-imidazol-5-yl)propyl]-4,5-dibromo-1-[(4-methoxyphenyl)methyl]pyrrole-2-carboxamide;hydrochloride |
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
| 5beta,6alpha-Bis[4-[(4,5-dibromo-1H-pyrrole-2-yl)carbonylaminomethyl]-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
|
Acinetobacter
Staphylococcus |
Biofilm
Biofilm |
Preclinical (in vitro)
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
| ZINC Lactate |
|
Acinetobacter |
PNAG |
Preclinical (in vitro) |
Peng Q, et al. 2020. Sci Rep |
|
| Rifampicin |
|
Acinetobacter
Klebsiella |
Biofilm
Capsule |
Preclinical (in vitro)
Preclinical (in vitro) |
Peng Q, et al. 2020. Sci Rep
Namikawa H, et al. 2019. Int J Antimicrob Agents |
|
| 3-cyclopropyl-5-(trifluoromethyl)-1-(3,4,5-trimethoxybenzoyl)-4,5-dihydro-1H-pyrazol-5-ol |
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Sambanthamoorthy K, et al. 2015. Bioorg Med Chem Lett |
|
| Oridonin |
|
Aeromonas |
Biofilm; Motility |
Preclinical (in vitro) |
Wang L, et al. 2024. Microorganisms |
|
| Luteolin |
|
Aeromonas |
Aerolysin |
Preclinical (in vitro) |
Dong J, et al. 2021. Virulence |
|
| 2-Hexyldecanoic acid |
|
Aeromonas |
Aerolysin |
Preclinical (in vitro) |
Arumugam M, et al. 2023. Antibiotics (Basel) |
|
| H-Pyran-4-one-2,3 dihydro-3,5 dihydroxy-6-methyl |
|
Aeromonas |
Aerolysin |
Preclinical (in vitro) |
Arumugam M, et al. 2023. Antibiotics (Basel) |
|
| Umbelliferone |
|
Aeromonas |
WhiB3 |
Preclinical (in vitro) |
Zhao L, et al. 2022. Int J Mol Sci |
|
| | | |
